MedTrace Logo

Toward Zero Prescribed Opioids for Outpatient General Surgery

NCT05327777 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2023-06-05

Study results available
· View outcomes & findings →

Summary

Investigators have created an opioid reduction "package" which includes patient education, non-narcotic pain control instructions, and limited (or no) opioid pain prescriptions provided at discharge in an attempt to reduce the number of opioid consumption after outpatient general surgery.

Conditions

  • Opioid Misuse and Addiction
  • Pain

Interventions

DRUG

Oxycodone

Investigators provided set opioid prescriptions for 10 pills each patient.

BEHAVIORAL

Zero Opioid Protocol

Investigators provided no opioid prescriptions at discharge and instead provided information on non-narcotic pain control.

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Francesco Palazzo, MD · Thomas Jefferson University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-07-30
Completion
2023-03-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05327777 on ClinicalTrials.gov